Scancell (LON:SCLP) Stock Price Crosses Below 200 Day Moving Average – What’s Next?

Scancell Holdings plc (LON:SCLP) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 9.88 ($0.13) and traded as low as GBX 9.73 ($0.13). Scancell shares last traded at GBX 10.95 ($0.15), with a volume of 1,472,135 shares changing hands.

Scancell Trading Up 9.5%

The company has a market capitalization of £113.36 million, a PE ratio of -16.78 and a beta of 0.35. The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The stock’s fifty day moving average price is GBX 9.77 and its two-hundred day moving average price is GBX 9.88.

Insider Buying and Selling at Scancell

In other news, insider Martin Diggle acquired 44,944 shares of the business’s stock in a transaction dated Tuesday, May 20th. The shares were purchased at an average price of GBX 9 ($0.12) per share, with a total value of £4,044.96 ($5,472.08). 4.96% of the stock is currently owned by corporate insiders.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.